Correlation Between Equillium and Carmell Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Equillium and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Carmell Therapeutics, you can compare the effects of market volatilities on Equillium and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Carmell Therapeutics.

Diversification Opportunities for Equillium and Carmell Therapeutics

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Equillium and Carmell is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Equillium i.e., Equillium and Carmell Therapeutics go up and down completely randomly.

Pair Corralation between Equillium and Carmell Therapeutics

Allowing for the 90-day total investment horizon Equillium is expected to generate 0.55 times more return on investment than Carmell Therapeutics. However, Equillium is 1.81 times less risky than Carmell Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  87.00  in Equillium on September 12, 2024 and sell it today you would lose (17.00) from holding Equillium or give up 19.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Equillium  vs.  Carmell Therapeutics

 Performance 
       Timeline  
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Carmell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Carmell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Equillium and Carmell Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Equillium and Carmell Therapeutics

The main advantage of trading using opposite Equillium and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.
The idea behind Equillium and Carmell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios